Accordingly, IL-33-deficient mice developed a dysregulated gut microbiota (Malik et al., 2016), and altered gut microbiota in IL-1α-knockout mice resulted in protection against DSS-induced colitis (Nunberg et al., 2018). Here, IL1A is linked to colitis.